-
1
-
-
0037687787
-
The role of chemotherapy in the current treatment of gastric cancer
-
Van Cutsem E, Haller D, Ohtsu A. The role of chemotherapy in the current treatment of gastric cancer. Gastric Cancer 2002; 5(Suppl 1): 17-22
-
(2002)
Gastric Cancer
, vol.5
, Issue.SUPPL. 1
, pp. 17-22
-
-
Van Cutsem, E.1
Haller, D.2
Ohtsu, A.3
-
2
-
-
0036946468
-
Chemotherapy in gastric cancer: A review and updated meta-analysis
-
Janunger KG, Hafstrom L, Glimelius B. Chemotherapy in gastric cancer: a review and updated meta-analysis. Eur J Surg 2002; 168: 597-608
-
(2002)
Eur. J. Surg.
, vol.168
, pp. 597-608
-
-
Janunger, K.G.1
Hafstrom, L.2
Glimelius, B.3
-
3
-
-
0036900097
-
Intravenous chemotherapy for resected gastric cancer: Meta-analysis of randomized controlled trials
-
Hu JK, Chen ZX, Zhou ZG, Zhang B, Tian J, Chen JP, Wang L, Wang CH, Chen HY, Li YP. Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials. World J Gastroenterol 2002; 8: 1023-1028
-
(2002)
World J. Gastroenterol.
, vol.8
, pp. 1023-1028
-
-
Hu, J.K.1
Chen, Z.X.2
Zhou, Z.G.3
Zhang, B.4
Tian, J.5
Chen, J.P.6
Wang, L.7
Wang, C.H.8
Chen, H.Y.9
Li, Y.P.10
-
4
-
-
0036583152
-
Adjuvant and preoperative chemotherapy for gastric cancer
-
Yao JC, Ajani JA. Adjuvant and preoperative chemotherapy for gastric cancer. Curr Oncol Rep 2002; 4: 222-228
-
(2002)
Curr. Oncol. Rep.
, vol.4
, pp. 222-228
-
-
Yao, J.C.1
Ajani, J.A.2
-
5
-
-
0037169358
-
Apoptosis: A link between cancer genetics and chemotherapy
-
Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002; 108: 153-164
-
(2002)
Cell
, vol.108
, pp. 153-164
-
-
Johnstone, R.W.1
Ruefli, A.A.2
Lowe, S.W.3
-
6
-
-
0034220882
-
Radiation-induced apoptosis: Predictive and therapeutic significance in radiotherapy of prostate cancer
-
Szostak MJ, Kyprianou N. Radiation-induced apoptosis: predictive and therapeutic significance in radiotherapy of prostate cancer. Oncol Rep 2000; 7: 699-706
-
(2000)
Oncol. Rep.
, vol.7
, pp. 699-706
-
-
Szostak, M.J.1
Kyprianou, N.2
-
7
-
-
0036215727
-
Effects of laser-induced thermotherapy (LITT) on proliferation and apoptosis of glioma cells in rat brain transplantation tumors
-
Schulze PC, Adams V, Busert C, Bettag M, Kahn T, Schober R. Effects of laser-induced thermotherapy (LITT) on proliferation and apoptosis of glioma cells in rat brain transplantation tumors. Lasers Surg Med 2002; 30: 227-232
-
(2002)
Lasers Surg. Med.
, vol.30
, pp. 227-232
-
-
Schulze, P.C.1
Adams, V.2
Busert, C.3
Bettag, M.4
Kahn, T.5
Schober, R.6
-
8
-
-
0034616945
-
Smac, a mitochondrial protein that pyomotes cytochrome c-dependent caspase activation by eliminating IAP inhibition
-
Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein that pyomotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000; 102: 33-42
-
(2000)
Cell
, vol.102
, pp. 33-42
-
-
Du, C.1
Fang, M.2
Li, Y.3
Li, L.4
Wang, X.5
-
9
-
-
0038297558
-
Expression of Smac/DIABLO in ovarian carcinoma cells induces apoptosis via a caspase-9-mediated pathway
-
McNeish IA, Bell S, McKay T, Tenev T, Marani M, Lemoine NR. Expression of Smac/DIABLO in ovarian carcinoma cells induces apoptosis via a caspase-9-mediated pathway. Exp Cell Res 2003; 286: 186-198
-
(2003)
Exp. Cell. Res.
, vol.286
, pp. 186-198
-
-
McNeish, I.A.1
Bell, S.2
McKay, T.3
Tenev, T.4
Marani, M.5
Lemoine, N.R.6
-
10
-
-
0037456993
-
Role of Smac in human leukaemic cell apoptosis and proliferation
-
Jia L, Patwari Y, Kelsey SM, Srinivasula SM, Agrawal SG, Alnemri ES, Newland AC. Role of Smac in human leukaemic cell apoptosis and proliferation. Oncogene 2003; 22: 1589-1599
-
(2003)
Oncogene
, vol.22
, pp. 1589-1599
-
-
Jia, L.1
Patwari, Y.2
Kelsey, S.M.3
Srinivasula, S.M.4
Agrawal, S.G.5
Alnemri, E.S.6
Newland, A.C.7
-
11
-
-
0347481285
-
Complications of gastrectomy following CPT-11-based neoadjuvant chemotherapy for gastric cancer
-
Marcus SG, Cohen D, Lin K, Wong K, Thorapson S, Rothberger A, Potmesil M, Hiotis S, Newman E. Complications of gastrectomy following CPT-11-based neoadjuvant chemotherapy for gastric cancer. J Gastrointest Surg 2003; 7: 1015-1022
-
(2003)
J. Gastrointest. Surg.
, vol.7
, pp. 1015-1022
-
-
Marcus, S.G.1
Cohen, D.2
Lin, K.3
Wong, K.4
Thorapson, S.5
Rothberger, A.6
Potmesil, M.7
Hiotis, S.8
Newman, E.9
-
13
-
-
1542472979
-
Apoptosis genes and resistance to cancer therapy: What does the experimental and clinical data tell us?
-
Brown JM, Wilson G. Apoptosis genes and resistance to cancer therapy: what does the experimental and clinical data tell us? Cancer Biol Ther 2003; 2: 477-490
-
(2003)
Cancer Biol. Ther.
, vol.2
, pp. 477-490
-
-
Brown, J.M.1
Wilson, G.2
-
14
-
-
1542322900
-
Why target apoptosis in cancer treatment?
-
Kasibhatla S, Tseng B. Why target apoptosis in cancer treatment? Mol Cancer Ther 2003; 2: 573-580
-
(2003)
Mol. Cancer Ther.
, vol.2
, pp. 573-580
-
-
Kasibhatla, S.1
Tseng, B.2
-
15
-
-
0344858928
-
Apoptosis: Targets in pancreatic cancer
-
Westphal S, Kalthoff H. Apoptosis: targets in pancreatic cancer. Mol Cancer 2003; 2: 6
-
(2003)
Mol. Cancer
, vol.2
, pp. 6
-
-
Westphal, S.1
Kalthoff, H.2
-
16
-
-
0038786580
-
Apoptosis-targeted therapies for cancer
-
Reed JC. Apoptosis-targeted therapies for cancer. Cancer Cell 2003; 3: 17-22
-
(2003)
Cancer Cell
, vol.3
, pp. 17-22
-
-
Reed, J.C.1
-
17
-
-
2442561553
-
Apoptosis as a novel target for cancer chemoprevention
-
Sun SY, Hail N Jr, Lotan R. Apoptosis as a novel target for cancer chemoprevention. J Natl Cancer Inst 2004; 96: 662-672
-
(2004)
J. Natl. Cancer Inst.
, vol.96
, pp. 662-672
-
-
Sun, S.Y.1
Hail Jr., N.2
Lotan, R.3
-
18
-
-
0038207814
-
Apoptosis: A mechanism of cell suicide
-
Derradji H, Baatout S. Apoptosis: a mechanism of cell suicide. In Vivo 2003; 17: 185-192
-
(2003)
In Vivo
, vol.17
, pp. 185-192
-
-
Derradji, H.1
Baatout, S.2
-
19
-
-
1542357606
-
Apoptosis pathways in cancer and cancer therapy
-
Debatin KM. Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immunother 2004; 53: 153-159
-
(2004)
Cancer Immunol. Immunother.
, vol.53
, pp. 153-159
-
-
Debatin, K.M.1
-
20
-
-
0036205587
-
Mechanisms of caspase activation and inhibition during apoptosis
-
Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 2002; 9: 459-470
-
(2002)
Mol. Cell
, vol.9
, pp. 459-470
-
-
Shi, Y.1
-
22
-
-
0036386545
-
Mitochondria and apoptosis: New therapeutic targets
-
Hockenbery DM, Giedt CD, O'Neill JW, Manion MK, Banker DE. Mitochondria and apoptosis: new therapeutic targets. Adv Cancer Res 2002; 85: 203-242
-
(2002)
Adv. Cancer Res.
, vol.85
, pp. 203-242
-
-
Hockenbery, D.M.1
Giedt, C.D.2
O'Neill, J.W.3
Manion, M.K.4
Banker, D.E.5
-
23
-
-
0037188903
-
Destabilizing influences in apoptosis: Sowing the seeds of IAP destruction
-
Martin SJ. Destabilizing influences in apoptosis: sowing the seeds of IAP destruction. Cell 2002; 109: 793-796
-
(2002)
Cell
, vol.109
, pp. 793-796
-
-
Martin, S.J.1
-
24
-
-
0346880501
-
The inhibitors of apoptosis: There is more to life than Bcl2
-
Liston P, Fong WG, Korneluk RG. The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 2003; 22 8568-8580
-
(2003)
Oncogene
, vol.22
, pp. 8568-8580
-
-
Liston, P.1
Fong, W.G.2
Korneluk, R.G.3
-
25
-
-
0036878240
-
Inhibitors of apoptosis proteins in injury and disease
-
Lotocki G, Keane RW. Inhibitors of apoptosis proteins in injury and disease. IUBMB Life 2002; 54: 231-240
-
(2002)
IUBMB Life
, vol.54
, pp. 231-240
-
-
Lotocki, G.1
Keane, R.W.2
-
26
-
-
0344442296
-
c-IAP1 is overexpressed in HL-60 cells selected for doxorubicin resistance: Effects on etoposide-induced apoptosis
-
Vaziri SA, Grabowski DR, Tabata M, Holmes KA, Sterk J, Takigawa N, Bukowski RM, Ganapathi MK, Ganapathi R. c-IAP1 is overexpressed in HL-60 cells selected for doxorubicin resistance: effects on etoposide-induced apoptosis. Anticancer Res 2003; 23: 3657-3661
-
(2003)
Anticancer Res.
, vol.23
, pp. 3657-3661
-
-
Vaziri, S.A.1
Grabowski, D.R.2
Tabata, M.3
Holmes, K.A.4
Sterk, J.5
Takigawa, N.6
Bukowski, R.M.7
Ganapathi, M.K.8
Ganapathi, R.9
-
27
-
-
0346250160
-
Survivin, versatile modulation of cell division and apoptosis in cancer
-
Altieri DC. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 2003; 22: 8581-8589
-
(2003)
Oncogene
, vol.22
, pp. 8581-8589
-
-
Altieri, D.C.1
-
28
-
-
0037030582
-
Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins)
-
Notarbartolo M, Cervello M, Dusonchet L, Cusimano A, D'Alessandro N. Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins). Cancer Lett 2002; 180: 91-101
-
(2002)
Cancer Lett.
, vol.180
, pp. 91-101
-
-
Notarbartolo, M.1
Cervello, M.2
Dusonchet, L.3
Cusimano, A.4
D'Alessandro, N.5
-
29
-
-
0036204018
-
Cell death regulation by the mammalian IAP antagonist Diablo/Smac
-
Verhagen AM, Vaux DL. Cell death regulation by the mammalian IAP antagonist Diablo/Smac. Apoptosis 2002; 7: 163-166
-
(2002)
Apoptosis
, vol.7
, pp. 163-166
-
-
Verhagen, A.M.1
Vaux, D.L.2
-
31
-
-
0036565885
-
Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis
-
Guo F, Nimmanapalli R, Paranawithana S, Wittman S, Griffin D, Bali P, O'Bryan E, Fumero C, Wang HG, Bhalla K. Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis. Blood 2002; 99: 3419-3426
-
(2002)
Blood
, vol.99
, pp. 3419-3426
-
-
Guo, F.1
Nimmanapalli, R.2
Paranawithana, S.3
Wittman, S.4
Griffin, D.5
Bali, P.6
O'Bryan, E.7
Fumero, C.8
Wang, H.G.9
Bhalla, K.10
-
32
-
-
0036341291
-
Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo
-
Fulda S, Wick W, Weller M, Debatin KM. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat Med 2002; 8 808-815
-
(2002)
Nat. Med.
, vol.8
, pp. 808-815
-
-
Fulda, S.1
Wick, W.2
Weller, M.3
Debatin, K.M.4
|